As shown in Figure 7B(left panel) RAMB1 treatment causes time-dependent (top) and dose-dependent (bottom) decrease of cyclin D1 levels suggesting failure of cervical cancer to enter the S- phase of the cell cycle as a cause of cell toxicity [41]. Here, CCND1 is linked to cervical carcinoma.